Uterine bleeding with hormone therapies in menopausal women: a systematic review
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Uterine bleeding with hormone therapies in menopausal women: a systematic review
Authors
Keywords
-
Journal
CLIMACTERIC
Volume -, Issue -, Pages 1-9
Publisher
Informa UK Limited
Online
2020-09-07
DOI
10.1080/13697137.2020.1806816
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Vaginal bleeding/spotting with conjugated estrogens/bazedoxifene, conjugated estrogens/medroxyprogesterone acetate, and placebo
- (2018) Risa Kagan et al. POSTGRADUATE MEDICINE
- The 2017 hormone therapy position statement of The North American Menopause Society
- (2017) MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Ultra-low-dose estradiol and norethisterone acetate: bleeding patterns and other outcomes over 52 weeks of therapy
- (2015) L-å. Mattsson et al. CLIMACTERIC
- Effectiveness, tolerability and acceptance of an oral estradiol/levonorgestrel formulation for the treatment of menopausal complaints: a non-interventional observational study over six cycles of 28 days
- (2014) Daniela Rouskova et al. GYNECOLOGICAL ENDOCRINOLOGY
- Effects of Bazedoxifene/Conjugated Estrogens on the Endometrium and Bone: A Randomized Trial
- (2014) JoAnn V. Pinkerton et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Factors Associated with Successful Discontinuation of Hormone Therapy
- (2014) Katherine M. Newton et al. JOURNAL OF WOMENS HEALTH
- Qualitative cross-cultural exploration of vaginal bleeding/spotting symptoms and impacts associated with hormone therapy in post-menopausal women to inform the development of new patient-reported measurement tools
- (2014) Rob Arbuckle et al. MATURITAS
- Differential effects of menopausal therapies on the endometrium
- (2014) Sebastian Mirkin et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- One-year randomized study of the endometrial safety and bleeding pattern of 0.25 mg drospirenone/0.5 mg 17β-estradiol in postmenopausal women
- (2013) A. R. Genazzani et al. CLIMACTERIC
- Effects of bazedoxifene/conjugated estrogens on endometrial safety and bone in postmenopausal women
- (2012) S. Mirkin et al. CLIMACTERIC
- Endometrial bleeding in postmenopausal women
- (2011) David F. Archer MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Ultra low dose continuous combined hormone replacement therapy with 0.5mg 17β-oestradiol and 2.5mg dydrogesterone: Protection of the endometrium and amenorrhoea rate
- (2010) C. Bergeron et al. MATURITAS
- Oral ultra-low dose continuous combined hormone replacement therapy with 0.5mg 17β-oestradiol and 2.5mg dydrogesterone for the treatment of vasomotor symptoms: Results from a double-blind, controlled study
- (2010) John C. Stevenson et al. MATURITAS
- Endometrium protection and acceptability of nasally administered continuously combined hormone therapy: a multicentre, multinational, double-blind trial in post-menopausal women evaluating three regimens of 17 -estradiol and norethisterone when compared with an orally administered 17 -estradiol norethisterone regimen
- (2009) S. Rozenberg et al. HUMAN REPRODUCTION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started